Enter Title

Darryl R. Peterson, Ph.D.

Professor, Physiology and Biophysics

Chicago Medical School
Building: BSB-3.262
Phone: 847-578-3274
Fax: 847-578-3265

Recent Publications


Peterson, D.R. and R.A. Hawkins. Transport studies using membrane vesicles.  In: Blood-Brain Barrier: Biology and Protocols.  Humana Press, Inc.  Totowa.  Pp, 233-247, 2003.

Neuwelt, E.A., M.A. Pagel, D.F. Kraemer, D.R. Peterson, and L.L. Muldoon.  Bone marrow chemoprotection without compromise of chemotherapy efficacy in rat brain tumor model. J. Pharmacol. Exp. Ther.  309: 1-6, 2004.

Doolittle, N.D., L.E. Abrey, W.A. Bleyer, S. Brem, T. Davis, P. Dorey-Duffy, L.R. Drewes, W.A. Hall, J.M. Hoffman, A.Korfel, R. Martuza, L.L. Muldoon, D. Peereboom, D.R. Peterson, S.D. Rabkin, Q. Smith, G. Stevens, and E.A. Neuwelt.  New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual blood-brain barrier disruption consortium meeting.  Cancer Res. 11: 421-428, 2005.

Peterson, D.R.  Blood-brain barrier. In: Encyclopedia of Life Sciences. Macmillan Reference Ltd., London, 2005.

Riser, B.L., S. Karoor, and D.R. Peterson. CCN genes and the kidney. In: CCN proteins: a new family of cell growth and differentiation regulators. B. Perbal and M. Takigawa, eds. Imperial College Press, UK, pp. 95-116, 2005.

Doolittle, N.D., D.M. Peereboom, G.A. Christoforidis, W.A. Hall, W.A.,  D. Palmieri, P.R. Brock, K. Campbell, D.T. Dickey, L.L. Muldoon, B.P. O’Neill, D.R. Peterson,  B. Pollock, C. Soussain, Q. Smith, R.M. Tyson, and E.A. Neuwelt. Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection in primary and metastatic brain tumors: report of the eleventh annual blood-brain barrier consortium meeting.  J. Neuro-Oncology, 2006.

Cooker, L., D.R. Peterson, J. Rambow, M. Riser, R. Riser, F. Najmabadi, D. Brigstock, and B. Riser.  TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis.  Am. J. Physiol.  F157-F165, 2007.

Dickey, D.T., L. L. Muldoon, N.D. Doolittle, D. R. Peterson, D.F. Kraemer, and E. A. Neuwelt.  Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced nephrotoxicity in rat models.  Cancer Chemother. Pharmacol.  62: 235-241, 2008.

Stenstrom, D.A., L.L. Muldoon, H. Armijo-Medina, S. Watnick, N. D. Doolittle, J. A. Kaufman, D.R. Peterson, J. Bubalo, and E.A. Neuwelt.  Can N-acetylcysteine prevent contrast induced nephropathy: Premature phase III trials.  J. Vasc. Interven. Radiol.  19: 309-318, 2008.

Riser, B.L., F. Najmabadi, B. Perbal, D.R. Peterson, J. Rambow, M.L. Riser. E. Sulowski, H. Yeger, and S.C. Riser.  CCN3 (Nov) is a negative regulator of CCN2 (CTGF) and an endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.  Am. J. Pathol. 174: 1725-1734  2009.

Riser, B.L., F. Najmabadi, B. Perbal, , J. Rambow, M.L. Riser. E. Sukowski, H. Yeger, S.C. Riser, and  D.R. Peterson.  CCN3 (Nov):  A negative regulator of CCN2 (CTGF) activity and an endogenous inhibitor of fibrosis in experimental diabetic nephropathy.  In: CCN Proteins in Health and Disease.  B. Perbal (ed.), pp. 163-181.  Springer Science and Business Media, 2010.

Riser, B.L., F. Najmabadi, B. Perbal, J. Rambow, M.L. Riser, E. Sukowski, H. Yeger, S.C. Riser, and D.R. Peterson.  CCN2/CCN3 regulation and the fibrosis of diabetic renal disease.  J. Cell Comm. Signaling 4: 39-50, 2010.

Hawkins R.A., J.R. Viña, D.R. Peterson, R. O’Kane, A. Mokashi, and I. A. Simpson.  Amino acid transport across each side of the blood-brain barrier. In: Amino Acids in Nutrition and Health. J.P.F. D’Mello, ed. CABI, pp. 191-214. CABI, Oxford,  2011.

Peterson, D.R.  Blood-brain barrier. In: Encyclopedia of Life Sciences. Macmillan Reference Ltd., London, 2012.

Peterson, D.R.  E.J. Sukowski, and D. Zikos.  Blood-brain barrier transport pathways for cytoprotective thiols.  Am J. Therapeutics, In press.